Jump to search

July 2020

Surge in firearm purchasing during pandemic’s onset linked to higher rates of firearm violence in U.S.

July 6, 2020

A surge in firearm purchasing in the U.S. during the coronavirus pandemic – estimated to be over 2.1 million excess purchases – is linked to a significant increase in firearm violence, a study by UC Davis Violence Prevention Program suggests.

June 2020

Unexpected spectrum of mental illnesses found in patients with rare genetic disorder

June 24, 2020

UC Davis MIND Institute researchers found an unexpected spectrum of mental illnesses in patients with a rare gene mutation. These patients had a “double hit” condition that combined features and symptoms of fragile X syndrome and premutation disorder, in addition to a range of psychiatric symptoms.

Pilot grants open door to better mental health care

June 24, 2020

The Behavioral Health Center of Excellence at UC Davis recented awarded seed funding to three projects designed to improve mental health research in California and strengthen collaborations with community, regional and statewide partners.

Defining paths to possible mother to child coronavirus transmission

June 23, 2020

UC Davis Health physicians defined the conditions of viral transmission from mother to baby during pregnancy and delivery.

Male contraception clinical trial launches in Sacramento

June 22, 2020

UC Davis Health is testing a potential new birth control option that could lead to the first male hormonal birth control on the market.

UC Davis study details use of extreme risk protection orders in California over first four years

June 18, 2020

The population-based study is one of the first to detail the early use of ERPOs in California. The policies help fill a gap in violence prevention efforts by allowing individuals to intervene when someone who is not prohibited from owning a firearm poses an immediate risk of violence to themselves or others.

UC Davis Health researchers win 2020 Chancellor’s Innovation Awards

June 15, 2020

Recipients of the UC Davis 2020 Chancellor’s Innovation Awards include four UC Davis Health researchers. 

NIH grant funds a new study of infants at higher risk for ADHD and ASD

June 11, 2020

A $3.65 million grant from NIH to fund Meghan Miller’s study of autism and ADHD markers in babies.

Izumiya, Tuscano, and Siefkes receive grants to advance innovative solutions with commercial potential

June 10, 2020

Three UC Davis Health researchers will receive grants to advance research and innovations with commercial potential.

Duchenne clinical trial offers promising results using unique therapy

June 9, 2020

UC Davis Health researchers say there is promising news about a potential stem cell-related treatment for people with the progressive genetic disorder known as Duchenne’s muscular dystrophy (DMD).

Pilot grants boost COVID-19 research

June 8, 2020

The Center for Healthcare Policy and Research, Center for Health and Technology and the Behavioral Health Center of Excellence at UC Davis have collaborated to fund projects that explore the effects of the COVID-19 pandemic on mental health, breast cancer screening, NICU care, children with disabilities and post-surgery therapies. 

May 2020

Autism severity can change substantially during early childhood

May 28, 2020

Kids with autism may have a change in their symptom severity during childhood. Around 30% of them have less symptoms by age 6.

The virtual museum experience: Can it help reduce social isolation and chronic pain?

May 28, 2020

Can participating in virtual, online museum programs help people with chronic pain feel more socially connected?  UC Davis Health is seeking volunteers to find out.

CTSC is a quiet hero of UC Davis COVID-19 research

May 26, 2020

The Clinical and Translational Science Center is an unsung hero of both UC Davis's COVID-19 research and its ongoing clinical trials.

Pilot study to assess intranasal compound for prevention of SARS-CoV-2 infection

May 20, 2020

Can an antiviral compound found in shellfish be effective against the novel coronavirus? The Covid Catalyst Fund awarded a grant to conduct a rule-out study.

Depression symptoms linked to reduced cognitive control in people with autism

May 19, 2020

Symptoms of depression in young adults with autism were linked to less proactive cognitive control, a new UC Davis MIND Institute study has found.

UC Davis Health identifies biomarker for early blood vessel damage due to sickle cell anemia

May 15, 2020

Unique computer-assisted microscope offers non-invasive, real-time approach to assess blood vessels

UC Davis researchers get $3 million FAST grant to find treatment for Angelman syndrome

May 14, 2020

Two UC Davis researchers receive $3 million grant to find an effective treatment for Angelman syndrome, a rare neurodevelopmental disorder.

Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?

May 12, 2020

UC Davis scientists provide senicapoc for COVID-19 clinical trial in Denmark.

Access to primary care differs by county for Medi-Cal patients

May 11, 2020

New research from UC Davis Health policy experts shows that Medi-Cal patients in Yolo County have better access to primary care than patients in nearby counties. Primary care access was worse in Sacramento, San Joaquin and Solano counties. 

New insight on maternal infections and neurodevelopmental disorders

May 5, 2020

The immune responses of a female mouse before pregnancy can predict how likely her offspring are to have behavioral deficits if the immune system is activated during pregnancy, according to researchers from the Center for Neuroscience at UC Davis. The findings, published in the journal Brain, Behavior, and Immunity, could help resolve what role serious infections during pregnancy play in the later development of conditions such as autism and schizophrenia in offspring.